Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LINC02464, or long intergenic non-protein coding RNA 2464, is a non-coding RNA gene identified in human genome annotations, represented by accessions such as NCBI Gene 105369854 and Ensembl ENSG00000257677. As a member of the long intergenic non-coding RNA (lincRNA) family, it does not encode a protein and may potentially participate in gene regulatory processes such as chromatin remodeling or transcriptional control, though its specific biological roles and disease relevance have not been characterized in the available literature or databases. There is no evidence that LINC02464 serves as a clinical biomarker, therapeutic target, or is modulated by existing drugs or therapies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2464 (LINC02464).